Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Fink

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
NPJ Vaccines|July 10, 2019
Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicityKatell Bidet, Victor Ho, Collins Wenhan Chu, et al.
NPJ Vaccines|November 1, 2019
Erratum: Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicityKatell Bidet, Victor Ho, Collins Wenhan Chu, et al.
Plos Pathogens|August 13, 2013
Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaquesRoland Züst, Hongping Dong, Xiao-Feng Li, et al.
American Journal of Respiratory Cell and Molecular Biology|September 30, 2022
A Unique CD27<sup>-</sup>IgD<sup>-</sup> B Cell Population in the Sputum of Severe Eosinophilic Asthma Associated with Airway AutoimmunityNadia Suray Tan, Manali Mukherjee, Sheau Yng Lim, et al.
Nature Medicine|November 6, 2007
Extralymphatic virus sanctuaries as a consequence of potent T-cell activationMike Recher, Karl S Lang, Alexander Navarini, et al.
Cell Reports|August 3, 2025
Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccineAriadna Grinyo-Escuer, Srikar Reddy, Agnes L Chenine, et al.
Scientific Reports|October 24, 2020
Single molecule, near full-length genome sequencing of dengue virusThiruni N Adikari, Nasir Riaz, Chathurani Sigera, et al.
JCI Insight|April 20, 2017
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infectionsYiu-Wing Kam, Cheryl Yi-Pin Lee, Teck-Hui Teo, et al.
Cell Reports. Medicine|June 7, 2021
Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infectionAngeline Rouers, Melissa Hui Yen Chng, Bernett Lee, et al.
Metabolism: Clinical and Experimental|December 14, 2020
Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mousePatrizia D'Adamo, Anemari Horvat, Antonia Gurgone, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
NPJ Vaccines|July 10, 2019
Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicityKatell Bidet, Victor Ho, Collins Wenhan Chu, et al.
NPJ Vaccines|November 1, 2019
Erratum: Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicityKatell Bidet, Victor Ho, Collins Wenhan Chu, et al.
Plos Pathogens|August 13, 2013
Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaquesRoland Züst, Hongping Dong, Xiao-Feng Li, et al.
American Journal of Respiratory Cell and Molecular Biology|September 30, 2022
A Unique CD27<sup>-</sup>IgD<sup>-</sup> B Cell Population in the Sputum of Severe Eosinophilic Asthma Associated with Airway AutoimmunityNadia Suray Tan, Manali Mukherjee, Sheau Yng Lim, et al.
Nature Medicine|November 6, 2007
Extralymphatic virus sanctuaries as a consequence of potent T-cell activationMike Recher, Karl S Lang, Alexander Navarini, et al.
Cell Reports|August 3, 2025
Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccineAriadna Grinyo-Escuer, Srikar Reddy, Agnes L Chenine, et al.
Scientific Reports|October 24, 2020
Single molecule, near full-length genome sequencing of dengue virusThiruni N Adikari, Nasir Riaz, Chathurani Sigera, et al.
JCI Insight|April 20, 2017
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infectionsYiu-Wing Kam, Cheryl Yi-Pin Lee, Teck-Hui Teo, et al.
Cell Reports. Medicine|June 7, 2021
Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infectionAngeline Rouers, Melissa Hui Yen Chng, Bernett Lee, et al.
Metabolism: Clinical and Experimental|December 14, 2020
Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mousePatrizia D'Adamo, Anemari Horvat, Antonia Gurgone, et al.
Pageof 9